Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Investigation of the peptide AOD9604 in an ovine osteochondral defect model
FDA inspects 503A compounders pursuant to its insanitary guidance standards rather than USP and compounders need to be fluent in the requirements of that Guidance
Q6: Can it be combined with other longevity therapies
Need ultrasonic and warming and heat to 60C Purity & Documentation Data Sheet (271 KB) SDS (394 KB) English - EN (394 KB) Franais - FR (394 KB) Deutsch - DE (394 KB) Norwegian - NO (394 KB) Espaol - ES (394 KB) Swedish - SV (394 KB) Italian - IT (394 KB) Korean - KR (394 KB) Portuguese - PT (394 KB) Handling Instructions (2659 KB) References Complete Stock Solution Preparation Table Please refer to the solubility information to select the appropriate solvent
US$ 20.33
US$ 21.22
US$ 28.23
US$ 23.43
